WC
MJN

Whitnell & Co’s Mead Johnson Nutrition Company MJN Stock Holding History

Whitnell & Co’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-216
Closed -$17K – 390
2013
Q2 		$17K Buy
+216
New +$17.3K 0.01% 244

Other funds holding MJN

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Whitnell & Co's MJN Position: Q3 2013 in Review

Whitnell & Co sold out of Mead Johnson Nutrition Company (MJN) in Q3 2013, closing a stake of 216 shares — an estimated $17K sold.

Whitnell & Co first reported a position in MJN in Q2 2013 and held it in 1 quarter. The position peaked at $17K in Q2 2013. 450 funds tracked by Wall St. Rank hold MJN as of Q3 2013.

  • Whitnell & Co reported no remaining Mead Johnson Nutrition Company position as of Q3 2013 after selling out during the quarter.
  • Whitnell & Co sold 216 Mead Johnson Nutrition Company shares in Q3 2013, an estimated $17K.
  • Whitnell & Co first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 1 quarter.
  • Whitnell & Co's Mead Johnson Nutrition Company position peaked at $17K in Q2 2013.
  • 450 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q3 2013.

Based on Whitnell & Co's 13F filing for Q3 2013, filed 12 Nov 2013.